Alfred W. Sandrock Jr. is the Executive Vice President and Chief Medical Officer at Biogen, Inc., and has served in this role since November 2015.  Since joining Biogen in 1998, Dr. Sandrock has held several senior executive positions including Group Senior Vice President of Development Sciences, Senior Vice President of Neurology Research and Development, and Vice President of Clinical Development, Neurology.  Prior to joining Biogen, Dr. Sandrock was Assistant Professor of Neurology at Harvard Medical School and an Assistant in Neurology at Massachusetts General Hospital.

Dr. Sandrock received a B.A. in Human Biology from Stanford University, an M.D. from Harvard Medical School, and a Ph.D. in Neurobiology from Harvard University.  He completed an internship in medicine, a residency and chief residency in neurology, and a clinical fellowship in neuromuscular disease and clinical neurophysiology (electromyography) at Massachusetts General Hospital in Boston, MA.

Dr. Sandrock is also a Director at Neurocrine Biosciences, Inc, Praxis Precision Medicines, Inc., and Disarm Therapeutics Inc., and is a member of the Partners Healthcare Innovation Advisory Board.  He serves as Chairman of the Board of the PhRMA Foundation.